Stereotactic Body Radiation Therapy for Intermediate-Risk Prostate Cancer: Five-Year Outcomes From a Multi-institutional Study

被引:6
|
作者
Meier, R. [1 ]
Beckman, A. C. [2 ]
Henning, G. [3 ]
Mohideen, N. [4 ]
Woodhouse, S. A. [5 ]
Williamson, S. [6 ]
Kaplan, I. D. [7 ]
机构
[1] Swedish Canc Inst, Seattle, WA USA
[2] Cent Baptist Hosp, Lexington, KY USA
[3] Huron River Radiat Oncol, Brighton, MI USA
[4] Northwest Community Hosp, Arlington, IL USA
[5] Community Canc Ctr, Normal, IL USA
[6] Capital Hlth, Trenton, NJ USA
[7] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
关键词
D O I
10.1016/j.ijrobp.2015.07.477
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1102
引用
收藏
页码:S199 / S199
页数:1
相关论文
共 50 条
  • [1] Five-Year Outcomes From a Multicenter Trial of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer
    Meier, R.
    Beckman, A.
    Henning, G.
    Mohideen, N.
    Woodhouse, S. A.
    Cotrutz, C.
    Kaplan, I. D.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S33 - S34
  • [2] Stereotactic Body Radiation Therapy for Intermediate-risk Organ-confined Prostate Cancer: Interim Toxicity and Quality of Life Outcomes From a Multi-institutional Study
    Meier, R.
    Kaplan, I.
    Beckman, A.
    Henning, G.
    Woodhouse, S.
    Williamson, S.
    Mohideen, N.
    Herold, D.
    Cotrutz, C.
    Sanda, M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S148 - S148
  • [3] Long-Term Outcomes of Stereotactic Body Radiation Therapy for Low and Intermediate-Risk Prostate Adenocarcinoma: A Multi-Institutional Consortium Study
    Kishan, A. U.
    Katz, A.
    Mantz, C. A.
    Chu, F. I.
    Appelbaum, L.
    Loblaw, D. A.
    Kaplan, I. D.
    Pham, H. T.
    Buyyounouski, M. K.
    Fuller, D. B.
    Meier, R.
    Collins, S. P.
    Shaverdian, N.
    Dang, A. T.
    Yuan, Y.
    Bagshaw, H. P.
    Prionas, N. D.
    Nickols, N.
    Steinberg, M. L.
    King, C. R.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S106 - S106
  • [4] Hypofractionated Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: A Multi-institutional Phase 2 Analysis
    Gill, B. S.
    Olsheski, M. E.
    DAmbrosio, D. J.
    Clump, D. A., II
    Wegner, R. E.
    Iyer, R.
    Burton, S. A.
    Holeva, K.
    Heron, D. E.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E197 - E198
  • [5] Outcomes of Stereotactic Body Radiation Therapy Delivered by Gantry-Based Linear Accelerators for Low and Intermediate-Risk Prostate Adenocarcinoma: A Multi-institutional Study
    Dang, A. T.
    King, C. R.
    Shabsovich, D.
    Mantz, C. A.
    Stephans, K. L.
    Loblaw, D. A.
    Cheung, P.
    Scorsetti, M.
    Cozzi, L.
    DeNittis, A. S.
    Wang, Y.
    Nickols, N.
    Kupelian, P. A.
    Steinberg, M. L.
    Kishan, A. U.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S107 - S107
  • [6] Stereotactic body radiotherapy boost toxicity for high and intermediate-risk prostate cancer: Report of a multi-institutional study
    Kaplan, Irving D.
    Appelbaum, Limor
    Aghdam, Nima
    Martin, Jarad
    Sidhom, Mark
    Pryor, David
    Aronovitz, Joseph A.
    Mahadevan, Anand
    Kennedy, Kevin F.
    Collins, Sean P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [7] Stereotactic body radiation therapy for low and intermediate risk prostate cancer-Results from a multi-institutional clinical trial
    Hannan, Raquibul
    Tumati, Vasu
    Xie, Xian-Jin
    Cho, L. Chinsoo
    Kavanagh, Brian D.
    Brindle, Jeffrey
    Raben, David
    Nanda, Akash
    Cooley, Susan
    Kim, D. W. Nathan
    Pistenmaa, David
    Lotan, Yair
    Timmerman, Robert
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 59 : 142 - 151
  • [8] Five-year Biochemical Control Rates for Stereotactic Body Radiation Therapy for Organ-confined Prostate Cancer: A Multi-institutional Pooled Analysis
    Katz, A.
    Freeman, D.
    Aronovitz, J.
    Fuller, D.
    Bolzicco, G.
    Meier, R.
    Collins, S.
    Wang, J.
    Steinberg, M.
    King, C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S147 - S148
  • [9] Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer
    Ju, Andrew W.
    Wang, Hongkun
    Oermann, Eric K.
    Sherer, Benjamin A.
    Uhm, Sunghae
    Chen, Viola J.
    Pendharkar, Arjun V.
    Hanscom, Heather N.
    Kim, Joy S.
    Lei, Siyuan
    Suy, Simeng
    Lynch, John H.
    Dritschilo, Anatoly
    Collins, Sean P.
    [J]. RADIATION ONCOLOGY, 2013, 8
  • [10] Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer
    Andrew W Ju
    Hongkun Wang
    Eric K Oermann
    Benjamin A Sherer
    Sunghae Uhm
    Viola J Chen
    Arjun V Pendharkar
    Heather N Hanscom
    Joy S Kim
    Siyuan Lei
    Simeng Suy
    John H Lynch
    Anatoly Dritschilo
    Sean P Collins
    [J]. Radiation Oncology, 8